𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Increased hepatotoxicity of tumor necrosis factor–related apoptosis-inducing ligand in diseased human liver

✍ Scribed by Xandra Volkmann; Ute Fischer; Matthias J. Bahr; Michael Ott; Frank Lehner; Marion MacFarlane; Gerald M. Cohen; Michael P. Manns; Klaus Schulze-Osthoff; Heike Bantel


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
921 KB
Volume
46
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Rheumatoid arthritis synovial fluid macr
✍ Harris Perlman; Nadine Nguyen; Hongtao Liu; Joy Eslick; Sybille Esser; Kenneth W 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

## Abstract ## Objective To characterize the expression pattern of tumor necrosis factor–related apoptosis‐inducing ligand (TRAIL) and its cognate receptors (TRAIL R1, R2, R3, and R4) on rheumatoid arthritis (RA) synovial fluid (SF) lymphocytes and monocyte/macrophages and on cultured RA synovial

PKCδ protects human breast tumor MCF-7 c
✍ Jindan Zhang; Ning Liu; Jingchun Zhang; Shilian Liu; Yanxin Liu; Dexian Zheng 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB

## Abstract Tumor necrosis factor (TNF)‐related apoptosis‐inducing ligand (TRAIL) induces apoptosis in a number of tumorogenic or transformed cells, yet is relatively non‐toxic to most normal cells, therefore, it is a promising agent for cancer therapy. However, some cancer cell lines were resistan

Emerging non-apoptotic functions of tumo
✍ Roberta Di Pietro; Giorgio Zauli 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB

## Abstract Tumor necrosis factor (TNF) is a cytokine that mediates tumor necrosis. To date, 20 different members of the TNF super‐family and 21 different receptors have been identified. All ligands of the TNF super‐family have been found to activate transcription factor NF‐κB and c‐Jun kinase. Mem

Role of HER-2/neu signaling in sensitivi
✍ Ki M. Kim; Yong J. Lee 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 530 KB

## Abstract Tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) has been shown to induce apoptosis in numerous transformed cell lines but not in most normal cells. Although this selectivity offers a potential therapeutic application in cancer, not all cancers are sensitive to TRAIL‐medi